Insulet ROE 2010-2025 | PODD
Current and historical return on equity (ROE) values for Insulet (PODD) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| Insulet ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| 2025-03-31 | $0.40B | $1.33B | 34.60% |
| 2024-12-31 | $0.42B | $1.21B | 40.79% |
| 2024-09-30 | $0.42B | $1.12B | 46.37% |
| 2024-06-30 | $0.40B | $1.00B | 50.61% |
| 2024-03-31 | $0.23B | $0.79B | 34.85% |
| 2023-12-31 | $0.21B | $0.73B | 34.36% |
| 2023-09-30 | $0.12B | $0.61B | 22.42% |
| 2023-06-30 | $0.06B | $0.55B | 12.85% |
| 2023-03-31 | $0.00B | $0.50B | 0.22% |
| 2022-12-31 | $0.00B | $0.48B | 1.13% |
| 2022-09-30 | $0.02B | $0.43B | 3.67% |
| 2022-06-30 | $0.04B | $0.42B | 7.28% |
| 2022-03-31 | $0.05B | $0.45B | 9.18% |
| 2021-09-30 | $-0.03B | $0.50B | -5.41% |
| 2021-06-30 | $-0.03B | $0.46B | -5.35% |
| 2020-12-31 | $0.01B | $0.60B | 1.54% |
| 2020-09-30 | $0.03B | $0.60B | 8.97% |
| 2020-06-30 | $0.02B | $0.56B | 8.48% |
| 2020-03-31 | $0.01B | $0.06B | 3.73% |
| 2019-12-31 | $0.01B | $0.08B | 6.28% |
| 2019-09-30 | $0.02B | $0.15B | 7.65% |
| 2019-06-30 | $0.02B | $0.25B | 7.69% |
| 2019-03-31 | $0.01B | $0.22B | 6.89% |
| 2018-12-31 | $0.00B | $0.21B | 1.58% |
| 2018-09-30 | $-0.01B | $0.20B | -7.92% |
| 2018-06-30 | $-0.02B | $0.18B | -12.35% |
| 2018-03-31 | $-0.02B | $0.17B | -20.47% |
| 2017-12-31 | $-0.03B | $0.16B | -29.83% |
| 2017-09-30 | $-0.03B | $0.07B | -43.61% |
| 2017-06-30 | $-0.03B | $0.07B | -46.69% |
| 2017-03-31 | $-0.03B | $0.06B | -47.49% |
| 2016-12-31 | $-0.03B | $0.06B | -61.88% |
| 2016-09-30 | $-0.05B | $0.07B | -121.05% |
| 2016-06-30 | $-0.06B | $0.03B | -174.65% |
| 2016-03-31 | $-0.07B | $0.03B | -157.84% |
| 2015-12-31 | $-0.07B | $0.03B | -121.67% |
| 2015-09-30 | $-0.05B | $0.06B | -70.34% |
| 2015-06-30 | $-0.04B | $0.07B | -54.60% |
| 2015-03-31 | $-0.06B | $0.08B | -70.59% |
| 2014-12-31 | $-0.05B | $0.08B | -56.04% |
| 2014-09-30 | $-0.05B | $0.08B | -48.40% |
| 2014-06-30 | $-0.06B | $0.08B | -52.91% |
| 2014-03-31 | $-0.04B | $0.12B | -32.41% |
| 2013-12-31 | $-0.05B | $0.13B | -35.80% |
| 2013-09-30 | $-0.05B | $0.12B | -48.96% |
| 2013-06-30 | $-0.04B | $0.14B | -48.62% |
| 2013-03-31 | $-0.05B | $0.13B | -66.43% |
| 2012-12-31 | $-0.05B | $0.04B | -91.48% |
| 2012-09-30 | $-0.06B | $0.05B | -83.97% |
| 2012-06-30 | $-0.06B | $0.06B | -77.29% |
| 2012-03-31 | $-0.05B | $0.07B | -61.82% |
| 2011-12-31 | $-0.05B | $0.08B | -57.50% |
| 2011-09-30 | $-0.05B | $0.08B | -69.97% |
| 2011-06-30 | $-0.05B | $0.09B | -80.31% |
| 2011-03-31 | $-0.06B | $0.06B | -111.76% |
| 2010-12-31 | $-0.06B | $0.07B | -131.89% |
| 2010-09-30 | $-0.06B | $0.03B | -123.76% |
| 2010-06-30 | $-0.06B | $0.04B | -165.99% |
| 2010-03-31 | $-0.07B | $0.04B | -268.00% |
| 2009-12-31 | $-0.07B | $0.06B | -394.59% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $22.033B | $2.072B |
| Insulet Corporation is a leading developer, manufacturer and marketer of the Omnipod Insulin Management System. The system is equipped with a self-adhesive, small and lightweight disposable tubeless Omnipod device along with the wireless and handheld Personal Diabetes Manager (PDM). The Omnipod System is an innovative, discreet and easy-to-use continuous insulin delivery system for people with insulin-dependent diabetes. The Omnipod System consists of Omnipod Insulin Management System ('Omnipod') and the Omnipod DASH Insulin Management System - Insulet's next generation digital mobile Omnipod platform. Insulet has tied up with pharmaceutical and biotechnological companies using customized form of the Omnipod System to deliver a drug at a certain administered volume and over a specified period of time. Insulet has partnered with pharmaceutical and biotechnology companies to tailor the Omnipod System technology platform for the delivery of subcutaneous drugs across other therapeutic areas. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $233.799B | 28.11 |
| Boston Scientific (BSX) | United States | $157.605B | 39.46 |
| Stryker (SYK) | United States | $150.214B | 31.41 |
| EssilorLuxottica (ESLOY) | France | $126.765B | 0.00 |
| Medtronic (MDT) | Ireland | $110.324B | 15.64 |
| Lonza Group Ag (LZAGY) | Switzerland | $50.804B | 0.00 |
| Haleon (HLN) | United Kingdom | $46.650B | 26.61 |
| ResMed (RMD) | United States | $37.413B | 28.10 |
| GE HealthCare Technologies (GEHC) | United States | $34.057B | 16.17 |
| Agilent Technologies (A) | United States | $33.852B | 22.07 |
| Terumo (TRUMY) | Japan | $27.835B | 36.15 |
| Koninklijke Philips (PHG) | Netherlands | $23.245B | 16.31 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.095B | 11.62 |
| Baxter (BAX) | United States | $15.595B | 11.64 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.236B | 0.00 |
| Demant (WILYY) | Denmark | $9.110B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $8.561B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.639B | 23.10 |
| Lantheus Holdings (LNTH) | United States | $5.638B | 14.22 |
| Prestige Consumer Healthcare (PBH) | United States | $3.998B | 17.86 |
| Perrigo (PRGO) | Ireland | $3.649B | 9.25 |
| Haemonetics (HAE) | United States | $3.545B | 16.15 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.334B | 27.70 |
| ICU Medical (ICUI) | United States | $3.244B | 23.92 |
| GN Store Nord (GNNDY) | Denmark | $2.307B | 19.11 |
| QuidelOrtho (QDEL) | United States | $1.952B | 13.43 |
| LeMaitre Vascular (LMAT) | United States | $1.866B | 41.70 |
| AtriCure (ATRC) | United States | $1.598B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.289B | 13.08 |
| Acuren (TIC) | United States | $1.271B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.111B | 25.00 |
| Phibro Animal Health (PAHC) | United States | $1.040B | 13.30 |
| Neogen (NEOG) | United States | $1.027B | 13.14 |
| BioLife Solutions (BLFS) | United States | $1.021B | 0.00 |
| Kestra Medical Technologies (KMTS) | United States | $0.907B | 0.00 |
| InMode (INMD) | Israel | $0.897B | 9.04 |
| Owens & Minor (OMI) | United States | $0.685B | 5.69 |
| CeriBell (CBLL) | United States | $0.683B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.629B | 0.00 |
| Evolus (EOLS) | United States | $0.589B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.531B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.509B | 0.00 |
| Valneva SE (VALN) | France | $0.494B | 0.00 |
| Surmodics (SRDX) | United States | $0.412B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.403B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.354B | 13.00 |
| Quanterix (QTRX) | United States | $0.332B | 0.00 |
| SNDL (SNDL) | Canada | $0.323B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.301B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.274B | 23.07 |
| Cerus (CERS) | United States | $0.271B | 0.00 |
| ZimVie (ZIMV) | United States | $0.258B | 11.72 |
| Sanuwave Health (SNWV) | United States | $0.256B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.253B | 0.00 |
| Brainsway (BWAY) | Israel | $0.250B | 66.10 |
| Cresco Labs (CRLBF) | United States | $0.246B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.233B | 69.17 |
| Biote (BTMD) | United States | $0.230B | 6.46 |
| OraSure Technologies (OSUR) | United States | $0.225B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.224B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.201B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.188B | 15.29 |
| Omeros (OMER) | United States | $0.188B | 0.00 |
| High Tide (HITI) | Canada | $0.184B | 0.00 |
| Organigram Global (OGI) | Canada | $0.181B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.177B | 0.00 |
| Exagen (XGN) | United States | $0.149B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.144B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.120B | 0.00 |
| Jin Medical (ZJYL) | China | $0.102B | 0.00 |
| Fonar (FONR) | United States | $0.092B | 11.90 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.088B | 0.00 |
| Veru (VERU) | United States | $0.085B | 0.00 |
| Apyx Medical (APYX) | United States | $0.082B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.078B | 0.00 |
| Zynex (ZYXI) | United States | $0.077B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.077B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.077B | 0.00 |
| MacroGenics (MGNX) | United States | $0.075B | 0.00 |
| InterCure (INCR) | Israel | $0.068B | 0.00 |
| Agape ATP (ATPC) | $0.066B | 0.00 | |
| ImmuCell (ICCC) | United States | $0.061B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.057B | 0.00 |
| Nephros (NEPH) | United States | $0.041B | 55.14 |
| United-Guardian (UG) | United States | $0.037B | 12.94 |
| Modular Medical (MODD) | United States | $0.037B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.027B | 0.00 |
| Safety Shot (SHOT) | United States | $0.023B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.018B | 0.00 |
| INLIF (INLF) | $0.016B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.014B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.014B | 0.00 |
| Flora Growth (FLGC) | United States | $0.014B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.012B | 0.00 |
| Senestech (SNES) | United States | $0.010B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.006B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |